TABLE 1.
Baseline characteristics study participants
| Variable | Hypertensive heart disease (n = 12) |
Healthy controls (n =19) |
P |
|---|---|---|---|
| Demographic characteristics | |||
| Age, year ± SD | 52 ± 16 | 41 ± 4 | 0.043 |
| Sex, n (%) | |||
| Women | 8 (67%) | 17 (89%) | 0.174 |
| Race | |||
| African American | 11 (92%) | 19 (100%) | 0.387 |
| SBP (mmHg) | 151 ± 14 | – | |
| DBP (mmHg) | 82 ± 12 | – | |
| Hypertension, n (%) | 12 (100%) | 0 | |
| Diabetes mellitus, n (%) | 2 (17%) | 0 | |
| Hyperlipidemia, n (%) | 7 (58%) | 0 | |
| Coronary artery disease, n (%) | 1 (8%) | 0 | |
| Medications | |||
| ACE-I/ARB, n (%) | 8 (66%) | 0 | |
| B-blocker, n (%) | 4 (33%) | 0 | |
| Calcium channel blocker, n (%) | 6 (50%) | 0 | |
| Diuretic, n (%) | 7 (58%) | 0 | |
| Statin, n (%) | 6 (50%) | 0 | |
| CMR variables | |||
| Left ventricular ejection fraction | 60.7 ± 12.9 | – | |
| End diastolic volume index | 60.2 ± 18.7 | – | |
| End systolic volume index | 24.3 ± 14.9 | – | |
| Left ventricular mass index | 76.6 ± 18.8 | – | |
| Stroke volume index | 35.7 ± 12.6 | – | |
| Cardiac index | 2.52 ± 0.74 | – | |
ACE-I, angiotensin converting-enzyme inhibitor; ARB, angiotensin receptor blocker; CMR, cardiac MRI. Values are mean ± SD, percentage (%).